Dr Duncan Wyncoll’s publications

  1. Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in TwoHospital Settings. Infect Dis Ther. 2014 Sep 10. [Epub ahead of print] Goldenberg SD, Bisnauthsing KN, Patel A, Postulka A, Wyncoll D, Schiff R, French GL
  2. Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial. Transfusion. 2014 May 5. doi: 10.1111/trf.12669. [Epub ahead of print] Jiwaji Z, Nunn KP, Conway-Morris A, Simpson AJ, Wyncoll D, Rossi AG, Walsh TS
  3. Long-term adherence to a 5-day antibiotic course guideline for treatment of intensive care unit (ICU)-associated Gram-negative infections. J Antimicrob Chemother. 2014 Feb 25 (Epub). Edgeworth JD, Chis Ster I, Wyncoll D, Shankar-Hari M, McKensie CA.
  4. Effects of prolonged mechanical ventilation with a closed suction system on endotracheal tube resistance and its reversibility by a closed suction cleaning system. Anaesth Intensive Care. 2013 Nov;41(6):728-35. Adi NA, Tomer NT, Bergman GB, Kishinevsky EK, Wyncoll DW
  5. Effects of prolonged mechanical ventilation with a closed suction system on endotracheal tube resistance and its reversibility by a closed suction system. Anaesth Intensive Care 2013;41:728-35. Adi NA, Tomer NT, bergman GB, JKishinevsky EK, Wyncoll D.
  6. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomised pilot trial. Crit Care Med 2013; 41: 2354-63. Walsh TS, BoydJA, Wyncoll D et al.
  7. Blood conservation devices in critical care: a narrative review. Ann Intensive Care 2013; 28:14. Page C, Retter A, Wyncoll D.
  8. Effects of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial. JAMA. 2013 May 22;309(20):2121-9. doi: 10.1001/jama.2013.5154. Young D(1), Harrison DA, Cuthbertson BH, Rowan K; TracMan Collaborators.
  9. Improved outcome of severe acute pancreatitis in the intensive care unit. Crit Care Res Pract. 2013;2013:897107. Pavlidis P(1), Crichton S, Lemmich Smith J, Morrison D, Atkinson S, Wyncoll D, Ostermann M.
  10. What size tube doctor? Bigger may be better - at least for weaning. Crit Care. 2013 Mar 27;17:422. O'Callaghan DJ, Wyncoll D.
  11. 'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. Matching Michigan Collaboration & Writing Committee. BMJ Qual Saf. 2013 Feb;22(2):110-23.
  12. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial. United Kingdom Clinical Infection Research Group. Trials 2012 Dec 18;13:241.
  13. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Retter A, Wyncoll D, et al; British Committee for Standards in Haematology. Br J Haematol. 2012 Dec 27. doi: 10.1111/bjh.12143.
  14. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DL; Intensive Care Study of Coagulopathy (ISOC) investigators. Transfusion. 2012 Aug 28. doi: 10.1111/j.1537-2995.2012.03866.x. [Epub ahead of print]
  15. Number needed to treat and cost-effectiveness in the prevention of ventilator-associated pneumonia. Wyncoll D, Camporota L. Crit Care. 2012 Jun 7;16(3):430. [Epub ahead of print]
  16. Fluoroquinolones in the treatment of severe CAP. Wilcox M, Finch R, Wyncoll D, et al. Br J Hosp Med. 2011 Dec:S1-7.
  17. Quantifying type-specific reproduction numbers for nosocomial pathogens: evidence for heightened transmission of an Asian sequence type 239 MRSA clone. Cooper BS, Kypraios T, Batra R, Wyncoll D, Tosas O, Edgeworth JD. PLoS Comput Biol. 2012 Apr;8(4):e1002454. Epub 2012 Apr 12.
  18. Prevalence, management and clinical challenges associated with acute faecal incontinence in the ICU and critical care settings: The FIRST™ cross-sectional descriptive survey. Bayón García C, Binks R, De Luca E, Dierkes C, Franci A, Gallart E, Niederalt G, Wyncoll D. Intensive Crit Care Nurs. 2012 Feb 29. [Epub ahead of print]
  19. The tracheal tube: gateway to ventilator-associated pneumonia. Zolfaghari PS, Wyncoll DL. Crit Care. 2011 Sep 29;15:310.
  20. The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis. Pérez-Casal M, Thompson V, Downey C, Welters I, Wyncoll D, Thachil J, Toh CH. Crit Care. 2011 Aug 11;15(4):R195.
  21. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D; Intensive Care Study of Coagulopathy (ISOC) investigators. Crit Care. 2011;15:R108.
  22. Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa. Shorr AF, Janes JM, Artigas A, Tenhunen J, Wyncoll DL, et al; RESPOND investigators. Crit Care. 2010;14(6):R229.
  23. A national clinical scenario-based survey of clinicians' attitudes towards fresh frozen plasma transfusion for critically ill patients. Watson DM, Stanworth SJ, Wyncoll D, et al. Transfus Med. 2011 Apr;21(2):124-9. doi: 10.1111/j.1365-3148.2010.01049.x. Epub 2010 Nov 10
  24. Managing anaemia in critically ill adults. Walsh TS, Wyncoll DL, Stanworth SJ. BMJ. 2010 Sep 3;341:c4408
  25. Prevalence, management and outcomes of critically ill patients with prothrombin time prolongation in UK ICUs.Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, Wyncoll D; Writing Committee of the Intensive Care Study of Coagulopathy (ISOC) Investigators. Crit Care Med. 2010 Jul 15. [Epub ahead of print]
  26. New versus old blood - the debate continues.Laurie J, Wyncoll D, Harrison C. Crit Care. 2010;14(2):130.
  27. Prevalence, management and outcomes of critically ill patients with prothrombin time prolongation in UK ICUs.Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, Wyncoll D; Writing Committee of the Intensive Care Study of Coagulopathy (ISOC) Investigators. Crit Care Med. 2010 Jul 15. [Epub ahead of print]
  28. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Clin Infect Dis. 2010; 50:210-7.
  29. Clinical application of real-time PCR to screening critically ill and emergency-care surgical patients for methicillin-resistant Staphylococcus aureus: a quantitative analytical study. Herdman MT, Wyncoll D, Halligan E, Cliff PR, French G, Edgeworth JD. J Clin Microbiol. 2009 Dec;47(12):4102-8. Epub 2009 Oct 21.
  30. Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy.Camporota L, Corno E, Menaldo E, Smith J, Lei K, Beale R, Wyncoll D. Crit Care. 2008;12(6):R163. Epub 2008 Dec 18.
  31. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Batra R, Eziefula AC, Wyncoll D, Edgeworth J.Intensive Care Med.Intensive Care Med. 2008 Sep;34(9):1703-6. Epub 2008 May 24.

1of 3